Delivery Order SPE2DB20D1100-SPE2DB24FB5D4
Award Date
4/29/24
Potential Completion Date
5/20/24
Potential Value
$51K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $106,187.70 firm fixed-price contract is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a specialty pharmaceutical product, with a ceiling value of $38,302.65 and a period of performance through July 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,285.85, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialized pharmaceutical product. The contract has a fixed-price delivery order structure and an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award and has no...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $48,668.88, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication, to support military healthcare programs. The contract is a Firm Fixed Price (FFP) arrangement and has an ultimate completion date of February 12, 2025. It is not designated as a set-aside contract....
This is a $17,523.90 firm fixed price delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML. The contract has an ultimate completion date of April 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,826.19, is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, with a period of performance running through November 20, 2024. The contract is not designated as a set-aside and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,100 mg/11 ml vials of the specialty medication ULTOMIRIS. The contract has a ceiling value of $51,082.04 and a period of performance through September 5, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML medical products. The contract, valued at $192,762.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a delivery order type with a firm fixed price pricing structure, and has an ultimate completion date of March 25, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML medication. The single-award delivery order contract has a total ceiling value of $42,558.50 and a period of performance through May 29, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a key...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ULTOMIRIS 1,100 mg/11 ml vials, with a potential value of $93,652.38 and a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a major supplier of pharmaceuticals and medical supplies to the Department...